Glaxosmithkline | GSK - Market Capitalization


Glaxosmithkline reported GBP107.91B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Bausch Health Companies USD 3.48B 873.55M Aug/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Drreddys Laboratories INR 11.07B 619M Mar/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
J&J USD 611.36B 32.21B Jun/2026
Merck USD 324.18B 6.81B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Pacira USD 1.28B 286M Aug/2026
Perrigo USD 1.45B 135M Aug/2026
Pfizer USD 153.17B 14.73B Aug/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.7B 463M Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Supernus Pharmaceuticals USD 2.58B 116M Aug/2026
Takeda JPY 8.2T 809.7B Jun/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
Zoetis USD 35.38B 5.25B Aug/2026